US 9198921
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted A61KA61K31/573A61K31/575
Quick answer
US patent 9198921 (Non-hormonal steroid modulators of NF-κB for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K31/573, A61K31/575, A61K45/06, A61P